A10BX02 • repaglinide • Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Other blood glucose lowering drugs, excl. insulins
Repaglinide is a medication used to control blood sugar levels in patients with type 2 diabetes. It stimulates the pancreas to release insulin, thereby helping to lower blood sugar levels after meals.
The medication is taken orally, usually before meals, and should be used as directed by your doctor. It is important to follow the recommended diet and exercise regimen to achieve the best results.
Side effects may include hypoglycemia (low blood sugar), nausea, diarrhea, or weight gain. In rare cases, severe allergic reactions or other complications may occur, requiring immediate medical attention.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as liver or kidney diseases, to ensure the safe use of repaglinide.
Substance: repaglinide
Date of last drug list: 01-01-2014
Commercial code: W60097005
Concentration: 2mg
Pharmaceutical form: tablets
Quantity: 270
Product type: generic
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.